LXRX FY 2017 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

LXRXLexicon Pharmaceuticals, Inc.

$693M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$90M+8.4% YoY

Gross Profit

$88M97.9% margin

Operating Income

-$137M-151.3% margin

Net Income

-$129M-142.9% margin

EPS (Diluted)

$-1.23

Cash Flow

Operating Cash Flow

-$185M

Free Cash Flow

-$186M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$437M

Total Liabilities

$384M

Stockholders' Equity

$52M

Cash & Equivalents

$311M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$90M	$83M	+8.4%
Gross Profit	$88M	-$81M	+209.7%
Operating Income	-$137M	-$137M	+0.3%
Net Income	-$129M	-$141M	+8.8%